Skip to main content
Top
Published in: Acta Diabetologica 6/2016

01-12-2016 | Case Report

Biventricular takotsubo cardiomyopathy in an elderly woman with uncontrolled type 2 diabetes: the biphasic echocardiographic and clinical pattern

Authors: Janusz Kochanowski, Radoslaw Piatkowski, Monika Budnik, Mariusz Jasik, Marek Roik, Grzegorz Opolski

Published in: Acta Diabetologica | Issue 6/2016

Login to get access

Abstract

We describe a case of an elderly woman who was diagnosed with a biventricular takotsubo cardiomyopathy (TTC) with combination of emotional stress and poorly controlled type 2 diabetes. We observed significant correlation between biphasic improvement of right (after 4 days) and left ventricle function (after 4 weeks) with normalization glycemic status. To our knowledge, this is the first reported case in the literature of biventricular TTC with such metabolic disturbances.
Literature
1.
go back to reference Budnik M, Kochanowski J, Piatkowski R et al (2016) Simple markers can distinguish Takotsubo cardiomyopathy from ST segment elevation myocardial infarction. Int J Cardiol 219:417–420CrossRefPubMed Budnik M, Kochanowski J, Piatkowski R et al (2016) Simple markers can distinguish Takotsubo cardiomyopathy from ST segment elevation myocardial infarction. Int J Cardiol 219:417–420CrossRefPubMed
2.
go back to reference Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ (2008) Translating the A1C assay into estimated average glucose values. Diabetes Care 31(8):1473–1478CrossRefPubMedPubMedCentral Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ (2008) Translating the A1C assay into estimated average glucose values. Diabetes Care 31(8):1473–1478CrossRefPubMedPubMedCentral
3.
go back to reference Madias JE (2016) Prevalence of diabetes in patients with takotsubo syndrome and controls without coronary artery disease in a Swedish cohort: scrutiny of statistics may be enlightening. Int J Cardiol 221:631CrossRefPubMed Madias JE (2016) Prevalence of diabetes in patients with takotsubo syndrome and controls without coronary artery disease in a Swedish cohort: scrutiny of statistics may be enlightening. Int J Cardiol 221:631CrossRefPubMed
4.
go back to reference Opolski G, Pawlak MM, Roik MF et al (2010) Clinical presentation, treatment, and long-term outcomes in patients with takotsubo cardiomyopathy. Experience of a single cardiology center. Pol Arch Med Wewn 120:231–236PubMed Opolski G, Pawlak MM, Roik MF et al (2010) Clinical presentation, treatment, and long-term outcomes in patients with takotsubo cardiomyopathy. Experience of a single cardiology center. Pol Arch Med Wewn 120:231–236PubMed
5.
go back to reference Oe K, Mori K, Otsuji M, Konno T, Fujino N, Yamagishi M (2008) Takotsubo cardiomyopathy with marked ST-segment elevation and electrical alternans complicated with hyperglycemic hyperosmolar state. Int Heart J 49:629–635CrossRefPubMed Oe K, Mori K, Otsuji M, Konno T, Fujino N, Yamagishi M (2008) Takotsubo cardiomyopathy with marked ST-segment elevation and electrical alternans complicated with hyperglycemic hyperosmolar state. Int Heart J 49:629–635CrossRefPubMed
Metadata
Title
Biventricular takotsubo cardiomyopathy in an elderly woman with uncontrolled type 2 diabetes: the biphasic echocardiographic and clinical pattern
Authors
Janusz Kochanowski
Radoslaw Piatkowski
Monika Budnik
Mariusz Jasik
Marek Roik
Grzegorz Opolski
Publication date
01-12-2016
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 6/2016
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-016-0916-3

Other articles of this Issue 6/2016

Acta Diabetologica 6/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine